Ignite Creation Date:
2024-05-06 @ 3:11 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04548752
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2020-09-12
Brief Title:
Testing the Addition of Pembrolizumab an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Pancreatic Cancer AJCC v8 |
| Metastatic Pancreatic Adenocarcinoma |
| Pancreatic Adenocarcinoma |
Keywords: